Provided by Tiger Trade Technology Pte. Ltd.

AbCellera Biologics

11.67
+0.26002.28%
Post-market: 11.60-0.0700-0.60%19:59 EDT
Volume:4.54M
Turnover:52.37M
Market Cap:3.78B
PE:-21.39
High:11.73
Open:11.44
Low:11.18
Close:11.41
52wk High:12.58
52wk Low:2.75
Shares:324.00M
Float Shares:221.00M
Volume Ratio:1.14
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5455
EPS(LYR):-0.4902
ROE:-17.30%
ROA:-10.39%
PB:4.22
PE(LYR):-23.81

Loading ...

AbCellera Q1 FY26 net loss narrows to $43.2 million; revenue rises to $8.3 million

Reuters
·
May 12

AbCellera Biologics Q1 EPS $(0.14) Beats $(0.20) Estimate, Sales $8.315M Beat $5.856M Estimate

Benzinga Earnings
·
May 12

BRIEF-AbCellera Q1 Revenue USD 8.3 Million Vs. IBES Estimate USD 5.86 Million

Reuters
·
May 12

Abcellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for Abcl635

THOMSON REUTERS
·
May 12

Press Release: AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635

Dow Jones
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

AbCellera to present at Bank of America Health Care Conference

Reuters
·
May 08

AbCellera Biologics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
May 06

Cantor Fitzgerald Initiates AbCellera Biologics at Overweight With $7 Price Target

MT Newswires Live
·
May 05

AbCellera initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
May 05

Earning Preview: AbCellera Biologics this quarter’s revenue is expected to decrease by 24%, and institutional views are bullish

Earnings Agent
·
May 03

AbCellera Biologics announces annual shareholder meeting notice

Reuters
·
Apr 30

A Look At AbCellera Biologics (ABCL) Valuation After Its Planned ABCL635 Phase 1 Data Update

Simply Wall St.
·
Apr 24

Press Release: AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call

Dow Jones
·
Apr 20

AbCellera updates financial calendar with upcoming quarterly earnings call

Reuters
·
Apr 20

Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)

TIPRANKS
·
Apr 15

How Investors Are Reacting To AbCellera Biologics (ABCL) After New Jones Trading Coverage Initiation

Simply Wall St.
·
Apr 13

AbCellera Biologics Initiated at Buy by Jones Trading

Dow Jones
·
Apr 10

AbCellera initiated with a Buy at JonesResearch

TIPRANKS
·
Apr 10